^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NBL-020

    i
    Other names: NBL-020
    Associations
    News
    Trials
    Company:
    CSPC Pharma
    Drug class:
    TNFRSF1B antagonist
    Related drugs:
    Associations
    News
    Trials